BusinessGVC Holdings Partners with Jumio to Focus on Improved Player ProtectionBy Nasdaq OMXFeb 7, 2018, 7:00 AM UTC
BusinessJumio’s Business Doubles in Just Ten Months, Exceeding 100 Million Identity VerificationsBy Nasdaq OMXFeb 1, 2018, 1:02 PM UTC
BusinessFDA Grants Orphan Drug Designation to Aptose Biosciences for CG’806 in Acute Myeloid LeukemiaBy Nasdaq OMXDec 26, 2017, 12:30 PM UTC
BusinessMeed Partners with Jumio to Improve Remote Identity Verification, KYC Compliance and Coverage for Its Global RolloutBy Nasdaq OMXDec 20, 2017, 1:01 PM UTC
BusinessCyclacel Announces Presentation of Results From Phase 3 Seamless Study at Ash Annual MeetingBy Nasdaq OMXDec 12, 2017, 12:01 PM UTC
BusinessOHSU and Aptose Present CG’806 Preclinical Data at ASH 59th Annual MeetingBy Nasdaq OMXDec 11, 2017, 9:04 PM UTC
BusinessRafael Pharmaceuticals to Present New Data Validating Efficacy of CPI-613 in Treating Acute Myeloid Leukemia at the 2017 American Society of Hematology Annual Meeting & ExpositionBy Nasdaq OMXDec 7, 2017, 1:55 PM UTC
BusinessFinom Blockchain Corp Announces Reg D Tokenized Equity OfferingBy Nasdaq OMXDec 4, 2017, 12:45 PM UTC
